Common use of Lapsed Targets and Terminated Targets Clause in Contracts

Lapsed Targets and Terminated Targets. On a Lapsed Target-by-Lapsed Target and Terminated Target-by-Terminated Target basis, CELGENE hereby grants to EPIZYME a royalty-free, worldwide, perpetual, non-exclusive right and license, with the right to grant sublicenses (subject to Section 5.2.6), under (a) the CELGENE Collaboration IP that is not Chemistry IP and (b) CELGENE’s interest in the Joint Collaboration Non-Chemistry IP, solely to the extent necessary to research, Develop, Manufacture, have Manufactured, use, offer for sale, sell, import and otherwise Commercialize Compounds Directed to such Lapsed Target or Terminated Target, as applicable, and related Diagnostic Products.

Appears in 3 contracts

Samples: Collaboration and License Agreement (Epizyme, Inc.), Collaboration and License Agreement (Epizyme, Inc.), Collaboration and License Agreement (Epizyme, Inc.)

AutoNDA by SimpleDocs

Lapsed Targets and Terminated Targets. On Subject to Section 7.1, on a Lapsed Target-by-Lapsed Target and Terminated Target-by-Terminated Target basis, CELGENE EPIZYME hereby grants to EPIZYME CELGENE a royalty-free, worldwide, perpetual, non-exclusive right and license, with the right to grant sublicenses (subject to Section 5.2.65.1.5), under (a) the CELGENE EPIZYME Collaboration IP that is not Chemistry IP and (b) CELGENEEPIZYME’s interest in the Joint Collaboration Non-Chemistry IP, solely to the extent necessary to research, Develop, Manufacture, have Manufactured, use, offer for sale, sell, import and otherwise Commercialize Compounds Directed to such Lapsed Target or Terminated Target, as applicable, and related Diagnostic Products.

Appears in 2 contracts

Samples: Collaboration and License Agreement (Epizyme, Inc.), Collaboration and License Agreement (Epizyme, Inc.)

AutoNDA by SimpleDocs

Lapsed Targets and Terminated Targets. On Subject to Section 7.1, on a Lapsed Target-by-Lapsed Target and Terminated Target-by-Terminated Target basis, CELGENE EPIZYME hereby grants to EPIZYME CELGENE a royalty-free, worldwide, perpetual, non-exclusive right and license, with the right to grant sublicenses (subject to Section 5.2.65.1.6), under (a) the CELGENE EPIZYME Collaboration IP that is not Chemistry IP and (b) CELGENEEPIZYME’s interest in the Joint Collaboration Non-Chemistry IP, solely to the extent necessary to research, Develop, Manufacture, have Manufactured, use, offer for sale, sell, import and otherwise Commercialize Compounds Directed to such Lapsed Target or Terminated Target, as applicable, and related Diagnostic Products.

Appears in 1 contract

Samples: Collaboration and License Agreement (Epizyme, Inc.)

Time is Money Join Law Insider Premium to draft better contracts faster.